Author

Brian E. Cohen

Observed names: B Cohen, B E Cohen, B. Cohen, BrianE. Cohen

Observed institutions: University of Maryland, Baltimore, Montefiore Einstein Comprehensive Cancer Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

OpenAlex ID: A5111772999

Effects of pH and temperature on the stability and decomposition of N,N'N"-triethylenethiophosphoramide in urine and buffer.

1984 · B E Cohen, M J Egorin, et al. · PubMed · 38

Gas-liquid chromatographic analysis of N,N′,Ntriethylene thiophosphoramide and N,N′,N″-triethylene phosphoramide in biological samples

1985 · Merrill J. Egorin, Brian E. Cohen, et al. · Journal of Chromatography B Biomedical Sciences and Applications · 24

Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion

1986 · N. Simon Tchekmedyian, Merrill J. Egorin, et al. · Cancer Chemotherapy and Pharmacology · 14

Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703.

2009 · B Ramaswamy, K Bhalla, et al. · Cancer Research · 10

On the search for new anticancer drugs 14: The plasma pharmacokinetics and tissue distribution of spin-labeled thio-TEPA (SL-O-TT)

1985 · PeterL. Gutierrez, BrianE. Cohen, et al. · Cancer Chemotherapy and Pharmacology · 7

A phase I study of thiotepa administered by short-term and protracted continuous intravenous infusion

1989 · Jacob J. Lokich, Merrill J. Egorin, et al. · Cancer · 6

Phase I dose-escalation study of ON 01910.Na in combination with oxaliplatin in patients with advanced solid tumors.

2010 · I. Chaudhary, L. Rajdev, et al. · Journal of Clinical Oncology · 1

Works count: 7

Citation count: 101

H-index: 6

I10-index: 4